KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Thermo Fisher Scientific (TMO) Invested Capital (2016 - 2025)

Historic Invested Capital for Thermo Fisher Scientific (TMO) over the last 17 years, with Q3 2025 value amounting to $86.5 billion.

  • Thermo Fisher Scientific's Invested Capital rose 288.16% to $86.5 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $86.5 billion, marking a year-over-year increase of 288.16%. This contributed to the annual value of $80.7 billion for FY2024, which is 98.94% down from last year.
  • Thermo Fisher Scientific's Invested Capital amounted to $86.5 billion in Q3 2025, which was up 288.16% from $85.5 billion recorded in Q2 2025.
  • In the past 5 years, Thermo Fisher Scientific's Invested Capital registered a high of $86.5 billion during Q3 2025, and its lowest value of $53.7 billion during Q2 2021.
  • In the last 5 years, Thermo Fisher Scientific's Invested Capital had a median value of $78.3 billion in 2022 and averaged $76.0 billion.
  • Per our database at Business Quant, Thermo Fisher Scientific's Invested Capital surged by 3794.02% in 2022 and then plummeted by 98.94% in 2024.
  • Thermo Fisher Scientific's Invested Capital (Quarter) stood at $75.5 billion in 2021, then grew by 3.69% to $78.3 billion in 2022, then increased by 4.03% to $81.5 billion in 2023, then fell by 0.99% to $80.7 billion in 2024, then grew by 7.26% to $86.5 billion in 2025.
  • Its Invested Capital was $86.5 billion in Q3 2025, compared to $85.5 billion in Q2 2025 and $83.4 billion in Q1 2025.